The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Leadership - ASLAN Pharmaceuticals; Etherna
Stock and Other Ownership Interests - ASLAN Pharmaceuticals; Etherna
Patents, Royalties, Other Intellectual Property - ASLAN Pharmaceuticals
A phase I study (E011-MEL) of a TriMix-based mRNA immunotherapy (ECI-006) in resected melanoma patients: Analysis of safety and immunogenicity.
 
ANA Maria Arance Fernandez
Honoraria - Amgen; Bristol-Myers Squibb; Merck; MSD; Novartis; Pierre Fabre; Roche
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Merck; MSD; Novartis; Pierre Fabre; Roche
Speakers' Bureau - Amgen; Bristol-Myers Squibb; Merck; MSD; Novartis; Pierre Fabre; Roche
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck; MSD; Roche
 
Jean-Francois Baurain
Consulting or Advisory Role - Bristol-Myers Squibb; MSD; Novartis
Research Funding - Amgen; MSD
Travel, Accommodations, Expenses - MSD
 
Christof Vulsteke
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Janssen; Leo Pharma; Merck Sharp & Dome; Novartis
Research Funding - Roche
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Novartis; Roche
 
Annemie Rutten
No Relationships to Disclose
 
Ainara Soria
Honoraria - Bristol-Myers Squibb; Merck; Novartis; Roche Pharma AG
Consulting or Advisory Role - Bristol-Myers Squibb; Merck; Novartis; Roche Pharma AG; Sanofi
Expert Testimony - Bristol-Myers Squibb; Merck; Novartis; Pierre Fabre; Roche Pharma AG
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck; Novartis; Roche Pharma AG
 
Javier Carrasco
Research Funding - AstraZeneca (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Roche
 
Bart Neyns
Honoraria - Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Roche
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Etherna; Merck Sharp & Dohme; Novartis; Pfizer/EMD Serono; Roche; Sanofi
Speakers' Bureau - Novartis
Research Funding - Merck KGaA (Inst); Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Roche
 
Brenda De Keersmaecker
Employment - eTheRNA; Grunenthal (I)
Stock and Other Ownership Interests - eTheRNA
 
Tim Van Assche
Employment - Etherna
Stock and Other Ownership Interests - Etherna
 
Bertil Lindmark
No Relationships to Disclose